Literature DB >> 33357535

Early Initiation of Evolocumab Markedly Reduces Low-Density Lipoprotein Cholesterol Levels After Myocardial Infarction.

Tomoaki Okada, Masayuki Doi, Toru Miyoshi, Kazumasa Nosaka, Satoshi Taya, Keisuke Yamamoto, Ai Sakamoto, Satoko Ugawa, Ryu Tsushima, Hiroshi Ito.   

Abstract

Entities:  

Year:  2020        PMID： 33357535     DOI： 10.1016/j.jcin.2020.08.026

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN： 1936-8798            Impact factor:   11.195


× No keyword cloud information.
  1 in total

1.  Effect of Early Initiation of Evolocumab on Lipoprotein(a) in Patients with Acute Myocardial Infarction: Sub-Analysis of a Randomized Controlled Trial.

Authors:  Tomoaki Okada; Toru Miyoshi; Masayuki Doi; Kazumasa Nosaka; Ryu Tsushima; Satoko Ugawa; Wataru Takagi; Masahiro Sogo; Masahiko Takahashi; Hiroshi Ito
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.